vs
Side-by-side financial comparison of NexPoint Residential Trust, Inc. (NXRT) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.
NexPoint Residential Trust, Inc. is the larger business by last-quarter revenue ($62.1M vs $49.0M, roughly 1.3× Quipt Home Medical Corp.). On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs -2.7%).
NexPoint Residential Trust, Inc. is a publicly traded real estate investment trust focused on acquiring, renovating, and operating multifamily residential properties primarily across high-growth Sun Belt markets in the United States. Its portfolio consists mainly of affordable and mid-tier apartment communities, targeting steady rental income growth and long-term asset value appreciation for investors.
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
NXRT vs QIPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $49.0M |
| Net Profit | — | $-1.1M |
| Gross Margin | — | 53.5% |
| Operating Margin | 8.4% | 2.1% |
| Net Margin | — | -2.1% |
| Revenue YoY | -2.7% | 32.3% |
| Net Profit YoY | — | 2.9% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $49.0M | ||
| Q3 25 | $62.8M | $39.8M | ||
| Q2 25 | $63.1M | $35.1M | ||
| Q1 25 | $63.2M | $33.3M | ||
| Q4 24 | $63.8M | $37.1M | ||
| Q3 24 | $64.1M | — | ||
| Q2 24 | $64.2M | — | ||
| Q1 24 | $67.6M | — |
| Q4 25 | — | $-1.1M | ||
| Q3 25 | $-7.8M | $-3.5M | ||
| Q2 25 | $-7.0M | $-3.0M | ||
| Q1 25 | $-6.9M | $-3.0M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | $-8.9M | — | ||
| Q2 24 | $10.6M | — | ||
| Q1 24 | $26.3M | — |
| Q4 25 | — | 53.5% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | 57.6% | ||
| Q1 25 | — | 54.6% | ||
| Q4 24 | — | 52.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 8.4% | 2.1% | ||
| Q3 25 | 11.8% | -3.6% | ||
| Q2 25 | 12.5% | -5.2% | ||
| Q1 25 | 11.7% | -3.0% | ||
| Q4 24 | 18.0% | 1.2% | ||
| Q3 24 | 8.7% | — | ||
| Q2 24 | 39.7% | — | ||
| Q1 24 | 60.7% | — |
| Q4 25 | — | -2.1% | ||
| Q3 25 | -12.4% | -8.9% | ||
| Q2 25 | -11.1% | -8.6% | ||
| Q1 25 | -10.9% | -9.1% | ||
| Q4 24 | — | -2.9% | ||
| Q3 24 | -13.8% | — | ||
| Q2 24 | 16.5% | — | ||
| Q1 24 | 38.9% | — |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $-0.31 | $-0.07 | ||
| Q2 25 | $-0.28 | $-0.07 | ||
| Q1 25 | $-0.27 | $-0.07 | ||
| Q4 24 | — | $-0.03 | ||
| Q3 24 | $-0.35 | — | ||
| Q2 24 | $0.40 | — | ||
| Q1 24 | $1.00 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.7M | $10.5M |
| Total DebtLower is stronger | $1.6B | $84.0M |
| Stockholders' EquityBook value | $295.5M | $113.0M |
| Total Assets | $1.9B | $280.7M |
| Debt / EquityLower = less leverage | 5.39× | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.7M | $10.5M | ||
| Q3 25 | $10.8M | $12.9M | ||
| Q2 25 | $13.6M | $11.3M | ||
| Q1 25 | $23.7M | $17.1M | ||
| Q4 24 | $23.1M | $15.5M | ||
| Q3 24 | $17.4M | — | ||
| Q2 24 | $21.3M | — | ||
| Q1 24 | $37.2M | — |
| Q4 25 | $1.6B | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $295.5M | $113.0M | ||
| Q3 25 | $322.9M | $112.1M | ||
| Q2 25 | $347.9M | $102.5M | ||
| Q1 25 | $379.9M | $103.6M | ||
| Q4 24 | $410.4M | $106.3M | ||
| Q3 24 | $447.1M | — | ||
| Q2 24 | $491.1M | — | ||
| Q1 24 | $512.8M | — |
| Q4 25 | $1.9B | $280.7M | ||
| Q3 25 | $1.8B | $283.3M | ||
| Q2 25 | $1.9B | $236.1M | ||
| Q1 25 | $1.9B | $244.6M | ||
| Q4 24 | $1.9B | $242.8M | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.0B | — |
| Q4 25 | 5.39× | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.92× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $83.6M | $8.9M |
| Free Cash FlowOCF − Capex | — | $6.9M |
| FCF MarginFCF / Revenue | — | 14.0% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $26.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.6M | $8.9M | ||
| Q3 25 | $29.3M | $9.8M | ||
| Q2 25 | $19.9M | $9.7M | ||
| Q1 25 | $28.3M | $8.9M | ||
| Q4 24 | $73.6M | $9.3M | ||
| Q3 24 | $27.8M | — | ||
| Q2 24 | $19.7M | — | ||
| Q1 24 | $19.7M | — |
| Q4 25 | — | $6.9M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | — | $5.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 20.0% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 14.9% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 0.75× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
